Effects of a Goal-directed Hemodynamic Therapy Driven by ECOM on Morbidity and Mortality After Cardiac Surgery?

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Coronary Surgery With Cardiopulmonary Bypass
Interventions
BEHAVIORAL

hemodynamic optimization strategy driven by the ECOM

"goal directed hemodynamic therapy is based on the ECOM evaluation of stroke volume variation (SVV) \& cardiac index (CI).~goals:~* SVV \< 11%~* IC \> 2,2 ml/min/m²~During the anesthesia"

BEHAVIORAL

standard management strategy

"goal directed hemodynamic therapy will be set and performed by the attending anesthetist, based on the analysis of further clinical parameters: Standard monitoring : heart rate, saturation index~* Diuresis \> 0,5ml/kg/h~* Blood pressure , PAM \> 65 mmHg~* Pulse pressure variation~* CVP 8 to 12 cmH20~* Visual aspect of the heart~* Overload signs During the anesthesia"

Trial Locations (1)

14000

University Hospital of Caen, Caen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CONMED Corporation

INDUSTRY

lead

University Hospital, Caen

OTHER